Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.

Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas

Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d

September 30, 2023

Misoprostol Alone in Self-Managed Abortion Is Highly Effective

Use of misoprostol alone was shown to be effective in self-managed abortion, with minimal side effects, according to a prospective observational cohort study of callers

October 28, 2023

FDA approves Servier’s VORANIGO for IGrade 2 glioma

A once-daily oral medication, the asset acts as an inhibitor for both IDH1 and IDH2 enzymes. Credit: danilo.alvesd on Unsplash. The US Food and Drug

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.